A Delaware Chancery Court last week heard arguments on amotion for a preliminary injunction filed by Eastman Kodak Co.against Cetus Corp. According to a Cetus spokeswoman, JudgeCarolyn Berger did not say when she would rule.
Kodak of Rochester, N.Y., is seeking to block the transfer ofCetus' polymerase chain reaction technology to Hoffmann-LaRoche. Emeryville, Calif.-based Cetus is selling the technologyfor $300 million as part of its merger with Chiron Corp.
In its August suit, Kodak claims the transfer would interferewith the pending arbitration between Kodak and Cetus overrights to commercialize the technology. The two sides are in theprocess of choosing arbitrators.
Cetus shares (NASDAQ:CTUS) closed at $17.50, down 13 cents, onThursday.
(c) 1997 American Health Consultants. All rights reserved.